SCHEMBL16217602

SCHEMBL16217602

C[C@@H]1C[C@@H](CO)N(N)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31737638 0.79 — —
SCHEMBL15743726 0.79 — —
SCHEMBL6628886 0.79 — —
SCHEMBL15744076 0.79 — —
SCHEMBL20016966 0.79 — —
SCHEMBL21230409 0.79 — —
SCHEMBL14535578 0.73 — —
SCHEMBL25692479 0.73 — —
SCHEMBL18747365 0.71 — —
SCHEMBL27643029 0.71 ENGASE (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9051326-B2 Pyrazoline derivatives and their use as selective androgen receptor modulators NOVARTIS AG (CH) 2015-06-09 — — US disclosed
US-20140329876-A1 PYRAZOLINE DERIVATIVES AND THEIR USE AS SELECTIVE ANDROGEN RECEPTOR MODULATORS NOVARTIS AG (CH) 2014-11-06 — — US disclosed
Send feedback